SDC1 and Miyoshi myopathy: Analyzing our total cohort of BM MNCs from MM patients, we found a significant decrease of both the percentage of CD138+ cells (Fig. 5a) (p < 0.0001) and of the MFICD138 (Fig. 5b) (p < 0.0001) after BVDV treatment compared to the control.